CollaborateMD vs Kareo: Which One in 2026?

If the chart is tolerable and the claim path is the fire, pick CollaborateMD. If you want one login for notes, eligibility, claims, scheduling, patient messaging, and the public site, pick Kareo. They are not close once you name the job. A medical practice that needs billing-only on top of a hospital EHR it cannot replace will feel the gap in a full-suite buy; a practice that is drowning in pajama-time charting will feel the gap in a billing-only buy. This page does not name a third product to fill that gap. Ask each vendor for a written quote that covers seats, modules, clearinghouse, migration, and the BAA — neither list price belongs in this article.

How we evaluated

The criteria were operational, and they were fixed before the homepages were opened.

Criterion one: does the product replace the chart, or does it sit next to the chart. CollaborateMD's public site leads with medical billing, a built-in clearinghouse, ERA auto-posting, denial management, real-time eligibility, patient payments, and AI-powered import of encounter data from other EHRs. Kareo's public URL now presents a cloud EHR plus billing, patient experience, and marketing for independent practices. That split decided the rest of the page.

Criterion two: who can administer it on a Tuesday morning. CollaborateMD is a biller-and-office-manager product. Kareo is a provider-and-front-desk product that also bills.

Criterion three: HIPAA as a shared-responsibility contract. A BAA is necessary and not sufficient. The practice still has to keep PHI off products that are not covered, control who can see claims and notes, and produce the designated record set on the access clock.

Criterion four: we printed no vendor prices, no clean-claim percentages next to a name, no provider counts, and no "days to go live" promises. Neither product had a figure in the vendor store we are allowed to repeat. Where a cell would have been a guess, it reads "not published."

US Tech Automations used regulator numbers for visit volume, EHR adoption, complaint volume, and the access clock, and we dated them. We did not use vendor case-study numbers.

The reader is medical practices: office-based clinics that still live and die by the claim, the front desk, and the no-show list. Hospital contact centers and payer member services are a different buy.

Who CollaborateMD is actually for

CollaborateMD is for the practice or billing company that wants to fix claims without ripping out the EHR. The public site leads with intelligent practice management and medical billing in one cloud platform. Billing-first workflows, a built-in clearinghouse, claim scrubbing, denial management, real-time eligibility, patient payments, lab interfaces to Quest Diagnostics, LabCorp, and LabDAQ, and AI-powered Universal Import from other EHRs are the jobs on that homepage.

That is the right shape when Advanced-style billing is the failure and providers will not sit through a new note template. Keep the chart, replace the claim path. Front-office pieces exist — scheduling, digital check-in, eligibility — but they are sold as the path into billing, not as a full clinical operating system.

CollaborateMD is a poor fit when the complaint is pajama-time charting, a dead portal, or a public website that does not convert. It is also a poor fit if you needed a single-vendor EHR you can take to a hospital credentialing meeting as the chart. Importing encounters is not the same as owning the note.

Ask for a quote that names clearinghouse, ERA posting, how many EHRs are in the interface list, whether Universal Import is in the SKU, enrollment, and training. Implementation is described as phased, with a dedicated enrollment specialist; treat that as a process claim, not a calendar.

Who Kareo is actually for

Kareo is for the buyer whose shortlist still says "Kareo Clinical" or "Kareo Billing." On the public web, the Kareo URL presents an EHR-plus platform for independent practices: cloud charting, e-prescribing, telehealth, labs, provider scheduling, claims, patient payments, digital intake, two-way messaging, reminders, reputation, and a custom website, with AI note assist and AI review replies in the current story. HIPAA, HITRUST, and SOC-style badges sit on that page. Treat those as homework items to confirm in the BAA, not as a substitute for one.

That is the right shape when the office is losing patients to a weak web presence, no-shows, or a portal that does not match how people book, and when providers will live in the same login as billing. It is the wrong shape when you need billing-only on top of a hospital EHR you cannot replace.

Do not run two RFPs against the same current suite. Ask the rep to map legacy Kareo module names to current SKUs so you are not quoted twice, and cross off marketing modules if you only wanted claims.

Kareo is a poor fit when the only fire is denials and the chart must stay. That is the CollaborateMD job.

Criteria scorecard

Read the table as the criteria, not as a ranking. "Native" means the product is sold to do that job. "Import" means the chart stays elsewhere. "not published" means we will not guess.

Source: product facts from CollaborateMD's homepage and the current Kareo URL, retrieved 2026-09-06. Price cells are not published.

The remaining fight is not "do we have an EHR." It is whether eligibility, claims, and PA move at the same speed as the note.

Source: ONC, National Trends in Hospital and Physician Adoption of Electronic Health Records; CDC NCHS FastStats, physician office visits.

91% of office-based physicians had a certified EHR as of 2024. Buying another chart without a claim path is how groups repeat last year's denial meeting.

Source: HHS OCR, Numbers at a Glance, content last reviewed 21 Nov 2024.

Source: eCFR 45 CFR 164.524, current as of 1 Sep 2026.

Pros and cons

CollaborateMD

Pros. You can keep the chart. Built-in clearinghouse, claim scrubbing, ERA posting, and denial workflows are the jobs the product is sold to do. Universal Import is the public answer to "we will not remap every EHR by hand." Billing companies and labs are named buyers, which matches a practice that outsources claims.

Cons. Importing encounters is not owning the note. Marketing, two-way patient inbox, and a public website are not the center of the homepage. Quote math is modules, interfaces, and enrollment — none of which this page can print. If pajama-time charting is the partner complaint, this is the wrong meeting.

Kareo

Pros. The product is the independent-practice operating system: chart, claim, schedule, message, and marketing in one login story. AI note assist and review replies are in the current product story. Front desk and providers can share a patient thread. Migration and training are sold as a process.

Cons. You are buying a suite, not a billing-only overlay. A hospital EHR you cannot replace will fight this login. Public list price is not printed here, so finance will not see a simple per-provider line until you ask. If you later need billing-only on top of a chart you must keep, you will be stretching a suite.

What switching actually costs

The invoice is the smallest part of the switch, and this page will not invent that invoice. The month it takes is a mix of enrollment, charge-master mapping, retraining, dual-run, and re-papering HIPAA. None of those calendars were published as a vendor figure we can reprint.

Enrollment and clearinghouse. Payer enrollment is a freeze window. You keep the old claim path live until the new one posts ERAs, then you watch rejection reports for a week. Ask both vendors who owns enrollment, what happens if a payer lags, and how ERA auto-posting is turned on. Put the answers in the quote packet.

Chart and encounter history. On CollaborateMD you import encounters and keep the old EHR reachable. On Kareo you migrate charts into the new EHR. Either way, according to the eCFR, the covered entity must act on a request for access no later than 30 days after receipt of the request. "We switched billers" is not a denial ground.

Retraining. CollaborateMD retraining is a biller change: new claim editor, new denial queue, new eligibility screen. Kareo retraining is an EHR change plus a front-desk change. Budget huddles for providers who only chart from a laptop at 9 p.m., and a cheat sheet for the front desk that still answers the main number.

Dual-run month. Keep the old clearinghouse submitting until clean-claim and days-in-AR look normal. Do not cancel the old contract on the cutover morning.

People. A CollaborateMD cutover needs an owner who can work a denial at 7:40 a.m. A Kareo cutover needs that person plus a provider champion. Name those people before you sign.

Source: switching cells are qualitative or not published. No vendor price or duration is printed.

When a rejection should become a next-morning task instead of a pile of payer codes, US Tech Automations can sit on that handoff — pull the rejection, extract the claim ID, and open the queue — without pretending to be the biller.

When self-scheduling must leave the public site and land on the right slot, US Tech Automations can own that workflow step on top of the suite you pick, including the customer-service agent that should talk to a person only after eligibility has already been checked.

Those two steps are also where missed intake turns into denials. Pair this choice with patient self-scheduling if the calendar is the fire. Pair it with prescription refill automation if the phone tree is the fire. Survey-heavy clinics should keep patient satisfaction survey automation on the same partner meeting, not as a third PM vendor.

Verdict

Pick CollaborateMD if the decision you are defending is "fix claims, keep the chart." You want a built-in clearinghouse, denial workflows, and an import path from the EHR you already have. You have a biller who can own admin.

Pick Kareo if the decision you are defending is "one login for chart, claim, schedule, and the public site." You have a provider champion. You will still do HIPAA homework, because badges are not a BAA, but the product shape matches the floor.

Do not pick CollaborateMD as a silent substitute for an EHR. Do not pick Kareo as a silent substitute for billing-only overlay. If the practice needs both jobs, say that out loud. This vs page will not invent a third name to hold the other job. Sequence the buy: install billing first if AR is failing; install the suite first if the chart and the front desk are the fire.

85.2% of U.S. adults saw a clinician in 2024. That load is why a front desk cannot treat claims and intake as a side project.

according to ONC, 91% of office-based physicians and more than 99% of non-federal acute-care hospitals had adopted a certified EHR as of 2024. The remaining fight is whether eligibility, claims, and PA move at the same speed as the note.

according to CDC, 85.2% of adults had a visit with a doctor or other health care professional in 2024. The billing buy has to survive that volume on the claim file.

according to CDC, telemedicine use among physicians increased from 15.4% in 2019 to 86.5% in 2021. Physician telemedicine use rose to 86.5% in 2021. That load still lands on the claim file.

according to HHS OCR, 370,578 complaints were resolved, or 99% of 374,322 received, as of 31 October 2024. Volume is not a reason to buy either product. It is a reason to keep a paper trail of BAAs and covered-SKU lists.

Quote both vendors with the same worksheet: seats or users, modules, clearinghouse, interfaces, marketing add-ons, BAA, professional services, dual-run billing, and which objects are in or out. Bring the answers to pricing if you want the surrounding workflow priced in the same conversation. The homepage for that conversation is US Tech Automations.

FAQs

Which one should a medical practice pick in 2026?

CollaborateMD if you are replacing the claim path and keeping the chart; Kareo if you are replacing the independent-practice operating system. They solve different jobs, and a partner-ready verdict names the job first.

Can CollaborateMD replace the EHR without a new note template?

No. CollaborateMD imports encounters from other EHRs. It is not sold as the chart. Practices whose complaint is pajama-time documentation should not use it as an EHR substitute. Kareo is the product in this pair sold as the cloud EHR.

Does Kareo cover billing-only on top of a hospital chart you cannot move?

Not as its center of gravity. The current suite wants the chart in the same login. Billing-only overlay is the CollaborateMD job. Confirm any dual-EHR path in writing before you sign.

What belongs in the quote if neither vendor has a public figure here?

Ask for seats, modules, clearinghouse, interfaces, marketing add-ons, enrollment, training, the BAA, and how the dual-run month is billed. If a salesperson quotes a round figure without those lines, send the worksheet back.

How long does cutover take?

A published vendor calendar was not available, so this page does not print one. Plan for enrollment, charge-master mapping, retraining, archive export, BAA papering, and a dual-run of the old claim path. Name an owner for each workstream before you pick a go-live week.

Do claims and notes require a BAA?

If the record can include PHI, you need a BAA with the vendor that touches that record, and you must stay inside products covered by that BAA. Request the covered-SKU list. The 30-day access clock does not pause because you switched billers.

What happens to old encounters when a patient requests an electronic copy?

They may be part of the designated record set. You have a 30-day clock, with one written 30-day extension, to act on the request. Confirm export formats with the new vendor and keep the old EHR reachable until the export is verified.

Key Takeaways

• CollaborateMD is billing-first with a built-in clearinghouse; Kareo is the independent-practice EHR-plus suite.

• Print no list price for either product; quote seats, modules, enrollment, BAA, and migration instead.

• Importing encounters is not owning the note.

• Do not run two RFPs against the same current Kareo suite under two search names.

• ONC's EHR-adoption figures explain why the remaining fight is claims speed, not "do we have a chart."

• OCR's complaint record is why PHI on claims and notes is a partner-level risk.

• The 30-day access clock is a regulation; encounters have to be producible after you switch.

• If you need both billing-only overlay and a new EHR, sequence the buys; this page will not name a third product.

• US Tech Automations belongs on the rejection-queue and self-scheduling handoffs, not as a substitute for the PM vendor.

• Bring the same quote worksheet to both vendors, then review the surrounding workflow on the pricing page.